Jing Liu

Ya-Zhen Qin, Yu Wang, Lanping Xu, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk factors in patients undergoing haploidentical hematopoietic stem cell transplantation for high-risk childhood acute leukemia

Dong-Mei Han, Xiao-Li Zheng, Ling Zhu, 2017, International Journal of Hematology.

Haploidentical hematopoietic stem-cell transplantation for non-Hodgkin lymphoma with bone marrow involvement

Zi-Kuan Guo, Ling Zhu, Zhi-dong Wang, 2009, Leukemia & lymphoma.

Association of Persistent Minimal Residual Disease with Poor Outcomes of Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Yan-rong Liu, Yu-Hong Chen, Xiao-hui Zhang, 2018, Chinese medical journal.

Bortezomib in combination with IGEV chemotherapy regimen for a primary refractory Hodgkin's lymphoma of bone.

Ling Zhu, Zhi-dong Wang, L. Ding, 2009, Leukemia research.

The significance of peri-transplantation minimal residual disease assessed by multiparameter flow cytometry on outcomes for adult AML patients receiving haploidentical allografts

Yan-rong Liu, Yu-Hong Chen, Xiao-hui Zhang, 2018, Bone Marrow Transplantation.

Infusion of haploidentical HSCs combined with allogenic MSCs for the treatment of ALL patients

N. Mao, Dong-Mei Han, H. Ning, 2022, Bone Marrow Transplantation.

Clinical analysis of the treatment of spinal cord injury with umbilical cord mesenchymal stem cells.

Dong-Mei Han, Xiao-Li Zheng, Zi-Kuan Guo, 2013, Cytotherapy.

Successful desensitization of high level donor-specific anti-HLA antibody in patients with hematological diseases receiving haploidentical allografts

Dong-Mei Han, Hongmin Yan, Xiao-Li Zheng, 2022, Annals of Hematology.

Humanized anti-CD25 monoclonal antibody for prophylaxis of graft-vs-host disease (GVHD) in haploidentical bone marrow transplantation without ex vivo T-cell depletion.

C. Xun, Ling Zhu, M. Xue, 2003, Experimental hematology.

[A comparative study on early toxicity of conditioning regimen with or without antithymocyte globulin].

Yu-Hong Chen, Yu Wang, Xiao-hui Zhang, 2009, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

Cytomegalovirus-Specific T-Cell Transfer for Refractory Cytomegalovirus Infection After Haploidentical Stem Cell Transplantation: The Quantitative and Qualitative Immune Recovery for Cytomegalovirus

Yu-Hong Chen, Yu Wang, Xiao-hui Zhang, 2017, The Journal of infectious diseases.

Haploidentical hematopoietic stem cell transplantation in hematologic malignancies with G-CSF mobilized bone marrow plus peripheral blood stem cells grafts without T cell depletion: a single center report of 29 cases

Zi-Kuan Guo, Zhi-dong Wang, Hong-Min Yan, 2012, Leukemia & lymphoma.

[Clinical study on hematopoietic reconstitution in patients with leukemia by haploidentical bone marrow transplantation].

Ling Zhu, Hong-Min Yan, M. Xue, 2003, Zhongguo shi yan xue ye xue za zhi.

HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILD HEMATOLOGIC MALIGNANCIES WITH G-CSF-MOBILIZED MARROW GRAFTS WITHOUT T-CELL DEPLETION: A Single-Center Report of 45 Cases

Zi-Kuan Guo, Ling Zhu, Zhi-dong Wang, 2009, Pediatric hematology and oncology.

Co-transfusion of haplo-identical hematopoietic and mesenchymal stromal cells to treat a patient with severe aplastic.

Hongmin Yan, Zi-Kuan Guo, Zhi-dong Wang, 2010, Cytotherapy.

Low-dose foscarnet preemptive therapy for cytomegalovirus viremia after haploidentical bone marrow transplantation.

Zi-Kuan Guo, Ling Zhu, M. Xue, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Co-infusion of mesenchymal stromal cells has no effect on relapse and infection in patients with leukemia undergoing haploidentical hematopoietic stem cell transplant

Dong-Mei Han, Xiao-Li Zheng, Ling Zhu, 2015, Leukemia & lymphoma.

Tumor necrosis factor α in aGVHD patients contributed to the impairment of recipient bone marrow MSC stemness and deficiency of their hematopoiesis-promotion capacity

N. Mao, Dong-Mei Han, H. Ning, 2020, Stem Cell Research & Therapy.